The Multidrug Resistant Modulator HZ08 Reverses Multidrug Resistance via P-glycoprotein Inhibition and Apoptosis Sensitization in Human Epidermoid Carcinoma Cell Line KBv200-Reference-Cited by-同舟云学术

The Multidrug Resistant Modulator HZ08 Reverses Multidrug Resistance via P-glycoprotein Inhibition and Apoptosis Sensitization in Human Epidermoid Carcinoma Cell Line KBv200

Published:2012-02-16 Issue:05 Volume:62 Page:236-242
ISSN:0004-4172
Container-title:Arzneimittelforschung
language:en
Short-container-title:Arzneimittelforschung

Author:

Zhu Y.-L.¹,Cen J.²,Zhang Y.-Y.¹,Feng Y.-D.¹,Yang Y.¹,Li Y.-M.¹,Huang W.-L.³

Affiliation:

1. Department of Physiology, China Pharmaceutical University, Nanjing, P. R. China

2. Key Laboratory of Nature Medicine and Immune Engineering, Henan University, Kaifeng, P. R. China

3. Center of Drug Discovery, China Pharmaceutical University, Nanjing, P. R. China

Publisher

Georg Thieme Verlag KG

Subject

Drug Discovery

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0031-1301344.pdf

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rapid and sensitive UPLC–MS/MS method for determination of HZ08 in rat plasma and tissues: Application to a pharmacokinetic study of liposome injections;Journal of Pharmaceutical and Biomedical Analysis;2015-01

2. The effect of multidrug resistance modulator HZ08 on pharmacodynamics and pharmacokinetics of adriamycin in xenograft-nude mice;European Journal of Pharmaceutical Sciences;2015-01

3. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway;European Journal of Pharmacology;2013-11

4. Oncogenic potential of Cyclin Kinase Subunit-2 in cholangiocarcinoma;Liver International;2012-11-01